Min Xia
Impact in
- Biochemistry top 0.1%
- Phytochemicals and Antioxidant Activities
- Antioxidant Activity and Oxidative Stress
- Nephrology top 0.5%
Papers in
-
- Inflammasome and immune disorders 28
- Surgery 62
- Cholesterol and Lipid Metabolism 19
- Co-authors
- Krishna M. Boini (53 shared papers)Wenhua Ling (51 shared papers)Pin-Lan Li (14 shared papers)Justine M. Abais (20 shared papers)Pin‐Lan Li (46 shared papers)Dan Li (17 shared papers)Yang Zhang (2 shared papers)Honghui Guo (16 shared papers)
- Journals
- The FASEB Journal (19 papers)Cellular Physiology and Biochemistry (8 papers)Atherosclerosis (7 papers)The Journal of Clinical Endocrinology & Metabolism (7 papers)PLoS ONE (7 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Min Xia
279 papers receiving 11.1k citations
Min Xia's Hit Papers
Peers
Comparison fields: 5 of 165
- Biochemistry 1.8k
- Nephrology 844
- Endocrinology, Diabetes and Metabolism 1.5k
- Physiology 372
- Molecular Biology 4.9k
Countries citing papers authored by Min Xia
This map shows the geographic impact of Min Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Xia more than expected).
Fields of papers citing papers by Min Xia
This network shows the impact of papers produced by Min Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Xia. The network helps show where Min Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 297 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector? Hit paper breakdown → | 2014 | 759 |
| 2 | 2009 | 349 | |
| 3 | 2015 | 277 | |
| 4 | 2012 | 250 | |
| 5 | 2011 | 191 | |
| 6 | 2011 | 188 | |
| 7 | 2006 | 183 | |
| 8 | 2011 | 177 | |
| 9 | 2000 | 168 | |
| 10 | 2012 | 164 | |
| 11 | 2009 | 142 | |
| 12 | 2006 | 141 | |
| 13 | 2020 | 141 | |
| 14 | 2019 | 134 | |
| 15 | 2012 | 128 | |
| 16 | 2014 | 127 | |
| 17 | 2003 | 123 | |
| 18 | 2005 | 122 | |
| 19 | 2012 | 108 | |
| 20 | 2011 | 103 |
About Min Xia
Min Xia is a scholar working on Molecular Biology, Surgery, Epidemiology, Physiology and Immunology, having authored 297 papers that have together received 11.3k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (28 papers), Liver Disease Diagnosis and Treatment (19 papers), Cholesterol and Lipid Metabolism (19 papers), Atherosclerosis and Cardiovascular Diseases (18 papers), Calcium signaling and nucleotide metabolism (17 papers), Diet, Metabolism, and Disease (17 papers), Folate and B Vitamins Research (17 papers) and Renal Diseases and Glomerulopathies (16 papers). The work is most often cited by research in Biochemistry (1.8k citations), Nephrology (844 citations), Endocrinology, Diabetes and Metabolism (1.5k citations), Physiology (372 citations) and Molecular Biology (4.9k citations). Min Xia has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Krishna M. Boini, Wenhua Ling, Pin-Lan Li, Justine M. Abais, Pin‐Lan Li, Dan Li, Yang Zhang, Honghui Guo, Chun Zhang and Ruifang Sun. Their work appears in journals such as The FASEB Journal, Cellular Physiology and Biochemistry, Atherosclerosis, The Journal of Clinical Endocrinology & Metabolism and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.